At the time of writing, Dexcom Inc [DXCM] stock is trading at $87.09, up 0.89%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The DXCM shares have gain 10.00% over the last week, with a monthly amount glided 15.72%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dexcom Inc [NASDAQ: DXCM] stock has seen the most recent analyst activity on January 16, 2025, when Robert W. Baird upgraded its rating to a Outperform and also boosted its price target to $104 from $86. Previously, Robert W. Baird downgraded its rating to Neutral on July 26, 2024, and dropped its price target to $80. On July 26, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $75 on the stock. Redburn Atlantic started tracking the stock assigning a Neutral rating and suggested a price target of $130 on May 30, 2024. RBC Capital Mkts initiated its recommendation with a Outperform and recommended $165 as its price target on March 12, 2024. In a note dated April 17, 2023, Raymond James upgraded an Strong Buy rating on this stock and boosted its target price from $127 to $138.
For the past year, the stock price of Dexcom Inc fluctuated between $62.34 and $142.00. Currently, Wall Street analysts expect the stock to reach $104.5 within the next 12 months. Dexcom Inc [NASDAQ: DXCM] shares were valued at $87.09 at the most recent close of the market. An investor can expect a potential return of 19.99% based on the average DXCM price forecast.
Analyzing the DXCM fundamentals
According to Dexcom Inc [NASDAQ:DXCM], the company’s sales were 3.95B for trailing twelve months, which represents an 1.97% jump. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.19%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.31 and Total Capital is 0.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 85.81 points at the first support level, and at 84.52 for the second support level. However, for the 1st resistance point, the stock is sitting at 88.29, and for the 2nd resistance point, it is at 89.49.
Ratios To Look Out For
It is important to note that Dexcom Inc [NASDAQ:DXCM] has a current ratio of 2.46. Also, the Quick Ratio is 2.12, while the Cash Ratio stands at 0.36. Considering the valuation of this stock, the price to sales ratio is 8.60, the price to book ratio is 17.19 and price to earnings (TTM) ratio is 52.21.
Transactions by insiders
Recent insider trading involved Stern Sadie, EVP, Chief HR Officer, that happened on Dec 16 ’24 when 424.0 shares were sold. EVP, Chief Financal Officer, Sylvain Jereme M completed a deal on Dec 16 ’24 to sell 744.0 shares. Meanwhile, EVP, Chief Operating Officer Leach Jacob Steven sold 744.0 shares on Dec 16 ’24.
